As lead drug runs into a wall, Deciphera slims down its pipeline, puts 140 jobs on the chopping block
Barely a month after disappointing data shattered hopes for a major label expansion for the GI tumor drug Qinlock, Deciphera is making a major …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
